Log In
BCIQ
Print this Print this
 

Histone deacetylase (HDAC)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Histone deacetylase (HDAC)

BCIQ
Print ChartPrint this
0 0 1 0 0 0 0 0 2 0 1 0 0 2 0 0 1 0 0 0 0 0 1 0 1 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 10 10 5 12 3 2 3 0 1 0 1 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Autoimmune

0

1

0

1

0

0

0

Cancer

10

10

5

12

3

2

3

Diagnostic

1

0

0

0

0

0

0

Endocrine / Metabolic

1

0

1

0

0

0

0

Hematology

0

1

0

1

0

0

0

Infectious

0

0

1

0

0

0

0

Neurology

0

2

0

1

0

0

2

Transplant

0

0

1

0

0

0

0




 Products Targeting Histone deacetylase (HDAC)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

22

$23,133.2M

$466.1M

$2,358.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today